How methotrexate can change liver function tests
Methotrexate can affect the liver, so clinicians monitor liver function with blood tests (commonly AST and ALT) during treatment. Liver enzyme levels may rise after starting or increasing the dose, which can be a sign of liver irritation or injury. Persistent or worsening abnormalities raise concern for more serious liver damage. [1][2]
What liver injury from methotrexate can look like over time
The liver effects associated with methotrexate range from mild, reversible enzyme elevations to chronic liver injury. Risk increases with long-term use and with cumulative dose exposure, so the pattern and duration of abnormal liver tests matter when deciding whether to continue, reduce, or stop methotrexate. [1][2]
Who is at higher risk of methotrexate-related liver problems
People with additional liver risk factors are more likely to develop liver injury or significant fibrosis while on methotrexate. Risk is higher with heavy alcohol use and in people with pre-existing liver disease. Risk also increases with other causes of chronic liver stress, such as obesity and metabolic liver disease. [1][2]
What helps reduce the risk
Clinicians reduce risk by using the lowest effective methotrexate dose and by checking liver-related labs at regular intervals. If liver enzymes rise, the usual approach is dose adjustment and closer monitoring, and evaluation for other causes of liver test abnormalities. Avoiding alcohol is commonly recommended during methotrexate therapy. [1][2]
What symptoms should prompt urgent medical attention
Methotrexate liver injury may be silent early and show up first as abnormal lab results. If liver problems progress, symptoms can include jaundice (yellow skin/eyes), dark urine, pale stools, significant fatigue, nausea/vomiting, or right upper abdominal discomfort. These symptoms should be assessed urgently. [1][2]
Can methotrexate effects on the liver be reversed?
Mild, early liver enzyme elevations may improve after dose reduction or stopping methotrexate. More advanced damage (for example, significant fibrosis or cirrhosis) can be harder to reverse, which is why monitoring and dose decisions are important. [1][2]
How doctors decide whether to continue methotrexate
Decisions are based on trends in liver enzyme results and the presence of other liver risk factors. If abnormalities occur, clinicians typically recheck labs, review alcohol/medication and other liver causes, and consider imaging or further evaluation depending on severity and persistence. [1][2]
What patients ask most: “Do I need to stop if my liver tests are high?”
Not every elevation means immediate stopping, but it does trigger a reassessment. The safest next step is to follow the prescriber’s plan for repeat testing and dose modification, since thresholds and actions depend on how high the enzymes are, how fast they change, and your overall risk profile. [1][2]
---
Sources
[1] https://www.ncbi.nlm.nih.gov/books/NBK547956/
[2] https://www.drugs.com/sfx/methotrexate-side-effects.html